CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tibet Weixinkang Pharmaceutical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tibet Weixinkang Pharmaceutical Co Ltd
3F, Block 4, Industry Center, No. 5
Yuanqu South Road, Zone B, Lasa Economic
Phone: +86 8916601760p:+86 8916601760 LASA, TBT  850000  China Ticker: 603676603676
Business Summary
Tibet Weixinkang Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of chemical pharmaceutical preparations and their active pharmaceutical ingredient. The Company's main products include multivitamins for injection (12), multi-trace element injection, pediatric multivitamin injection (13), compound electrolyte injection (V), potassium magnesium aspartate injection, potassium aspartate injection and other products. The Company is also engaged in pharmaceutical marketing services. The Company mainly conducts its businesses in the domestic market.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager YongZhang 45
Chief Financial Officer, Secretary of the Board XiaopingXiong 42
Deputy General Manager, Director FengLiu 44
6 additional Officers and Directors records available in full report.

General Information
Number of Employees: 701 (As of 12/31/2023)
Outstanding Shares: 435,161,500 (As of 9/30/2024)
Shareholders: 14,834
Stock Exchange: SHA
Fax Number: +86 8916601760


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024